Search Within

Department of Medicine

Formats
  1. Journal Article (19627)
  2. Meeting Abstract (16084)
  3. Review (1160)
  4. Book Section (934)
  5. Editorial (612)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22376)
  2. Hematologic Malignancies, Division of (13310)
  3. Center for Hematologic Malignancies (11084)
  4. GSK Faculty (10660)
  5. Survivorship Research (9357)
  6. Division of Subspecialty Medicine (7562)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1168)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4217)
  3. American Society of Hematology (4004)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2306)
  6. Nature Publishing Group (2123)

More Publishers

Results (39721)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dopaminergic Neuronal Cell Therapy for Parkinson's Disease: Results from a Phase 1 Study of Bemdaneprocel
    Meeting Abstract

    Henchcliffe, C.; Sarva, H.; Lozano, A.; Fasano, A.; Kalia, S.; Brennan, C.; Yu, K.; Yountz, M.; Enayetallah, A.; Yountz, M.; more...
    Annals of Neurology (2023)

    Fulltext@MSK | Save
  • Tracking the earliest genomic events in multiple myeloma life-history
    Meeting Abstract

    Cirrincione, A.; Poos, A.; Kaddoura, M.; Ziccheddu, B.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; Papadimitriou, M.; Blaney, P.; Gagler, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion-positive NSCLC
    Journal Article

    Caicun, Z.; Solomon, B.; Loong, H. H.; Park, K.; Pérol, M.; Arriola, E.; Novello, S.; Han, B.; Zhou, J.; Ardizzoni, A.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer
    Journal Article

    Hadoux, J.; Elisei, R.; Brose, M. S.; Hoff, A. O.; Robinson, B. G.; Gao, M.; Jarzab, B.; Isaev, P.; Kopeckova, K.; Wadsley, J.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • ctDNA dynamics, prognostic markers, and mechanisms of resistance in tepotinib-treated MET exon 14 (METex14) skipping NSCLC in the VISION trial
    Meeting Abstract

    Xiuning, L.; Garassino, M. C.; Ahn, M . J.; Felip, E.; Cortot, A. B.; Hiroshi, S.; Mazières, J.; Thomas, M.; Viteri, S.; Conte, P.; more...
    Journal of Oncology Navigation & Survivorship (2023)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates durable efficacy and manageable safety in patients with relapsed/refractory follicular lymphoma and ≥2 prior therapies: Updated results from a pivotal phase 2 study
    Meeting Abstract

    Bartlett, N. L.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    Journal of Oncology Navigation & Survivorship (2023)

    Fulltext@MSK | Save
  • Patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC following EGFR TKI and platinum-based chemotherapy: HERTHENA-Lung01
    Meeting Abstract

    Yu, H. A.; Yasushi, G.; Hidetoshi, H.; Felip, E.; Chih-Hsin Yang, J.; Reck, M.; Yoh, K.; Lee, S. H.; Paz-Ares, L.; Besse, B.; more...
    Journal of Oncology Navigation & Survivorship (2023)

    Fulltext@MSK | Save
  • Fecal transplantation in hematopoietic transplantation
    Journal Article

    Peled, J. U.; van den Brink, M. R. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Quality of life before and after radiation therapy for early-stage keratinocyte carcinoma: A longitudinal analysis
    Journal Article

    Qin, N.; Ma, J.; Lee, E. H.; Barker, C. A.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save